Category Specific RSS

News

A beer fortune turnaround Broo-ing with large CUB order

Despite some struggles faced through COVID-19 shutdowns, beer producer Broo (ASX: BEE) could be on the move again having entered into a production agreement with Australia’s leading brewer Carlton and United Breweries (CUB). 

The order with CUB comes despite Broo owning and operating their own brewery facility in Mildura where they produce Broo Premium Lager and Australia Draught. 

Under the CUB agreement, Broo anticipates placing orders with CUB for a minimum of 48,000 cases of beer quarterly over the 2-year agreement. If minimum orders are met this equates to 384,000 cases of beer. 

Being based in Victoria, but with national distribution, Broo has been adversely affected by COVID-19 which has resulted in the shutdowns of their Sorrento Brewhouse and Mildura Pub, which have had a material impact on revenue. 

For the Quarter ending 30 June 2020, Broo reported $420k of revenue, which was significantly down on the $879k from the corresponding FY19 Quarter. 

While the Company has reduced its operating expenses in the tough trading conditions, their Mildura Brewery has continued to produce beer, suggesting any orders delivered by CUB of Broo Premium Lager and Australia Draught will be additional to Company-owned producing facilities. 

Having operated with a net loss of $137k for the June Quarter and $76k of cash on hand, Broo is seeking longer-term sources of capital. A major marketing push, backed up by CUB’s supply may just be what the Company needs to brew their post-COVID turnaround. 

 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago